Search

Author/Creator Moraschini, Luca

1. A detailed analysis of possible efficacy signals of NTHi-Mcat vaccine against severe COPD exacerbations in a previously reported randomised phase 2b trial. Issue 41 (29th September 2022)

Authors:
Arora, Ashwani K.; Chinsky, Kenneth; Keller, Claus; Mayers, Irvin; Pascual-Guardia, Sergi; Vera, Mercè Pérez; Lambert, Christophe; Lombardi, Stefano; Rondini, Simona; Tian, Sun; Ulloa-Montoya, Fernando; Moraschini, Luca; Casula, Daniela
Journal:
Vaccine
Issue:
Volume 40:Issue 41(2022)
Page Start:
5924
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults. Issue 1 (2nd January 2018)

Authors:
Leroux-Roels, Geert; Lattanzi, Maria; Solis, Claudia Dovali; Contorni, Mario; Costantini, Marco; Moraschini, Luca; Bardelli, Monia; Bertholet, Sylvie; Borgogni, Erica; Buricchi, Francesca; Cantisani, Rocco; Faenzi, Elisa; Finco, Oretta; Leuzzi, Rosanna; Pizza, Mariagrazia; Rosa, Domenico; Schiave...
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 14:Issue 1(2018)
Page Start:
45
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial. Issue 5 (May 2022)

Authors:
Andreas, Stefan; Testa, Marco; Boyer, Laurent; Brusselle, Guy; Janssens, Wim; Kerwin, Edward; Papi, Alberto; Pek, Bonavuth; Puente-Maestu, Luis; Saralaya, Dinesh; Watz, Henrik; Wilkinson, Tom M A; Casula, Daniela; Di Maro, Gennaro; Lattanzi, Maria; Moraschini, Luca; Schoonbroodt, Sonia; Tasciotti...
Journal:
Lancet
Issue:
Volume 10:Issue 5(2022)
Page Start:
435
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months–55 years. Issue 6 (2nd June 2020)

Authors:
Yoo, Byung Wook; Jung, Hye Lim; Byeon, Yoon Seob; Han, Dong Ki; Jeong, Nak Yeong; Curina, Carlo; Moraschini, Luca; Kim, Sung Jin; Bhusal, Chiranjiwi; Pellegrini, Michele; Miao, Yan
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 16:Issue 6(2020)
Page Start:
1260
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗